Heart failure & cardiomyopathies

Comparing New York Heart Association Class and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure

Circ Heart FailPublished Secondary analysis of the ASCEND-HF randomised trial

Authors' conclusion

In a global trial cohort of patients hospitalized for heart failure, the majority of patients exhibited discordance between clinician-reported NYHA class and patient-reported health status. Multiple patient factors were independently associated with moderate-severe discordance, and patients who perceived their health status as worse than the clinician's perception had higher mortality.

Study context

Population
Patients hospitalized for HF, irrespective of EF, with complete baseline New York Heart Association (NYHA) class and EQ-5D data
Participants
5,741 patients
Comparison
Clinician-reported NYHA class vs patient-reported EQ-5D
Primary endpoint
Concordance/discordance between NYHA class and EQ-5D (utility index and visual analog scale)
Methodological detailsglobal
  • Global

Primary result

As reported in the abstract

Agreement between NYHA class and EQ-5D

EQ-5D utility index

EQ-5D visual analog scale

Discordance due to disproportionately higher EQ-5D score, utility index
78%
Discordance due to disproportionately higher EQ-5D score, visual analog scale
70%

Further findings

Clinical outcomes by discordance · 180 days

ComparisonAdjusted HR (95% CI)P value
EQ-5D utility index worse than NYHA class180-day mortality1.27 (1.01–1.60)P = 0.04

Factors associated with moderate-severe discordance

NYHA class IV, higher EQ-5D scores, race and geographic region independently associated

Clinical outcomes by discordance · 180 days

Magnitude of discordance not associated with clinical outcomes

Original publication

Comparing New York Heart Association Class and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure. Circ Heart Fail. Published 31 October 2022. doi:10.1161/circheartfailure.122.010107

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.